Reviewed,
UniProtKB/Swiss-Prot P19256 (LFA3_HUMAN)
Last modified
July 22, 2008.
Version 93.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Lymphocyte function-associated antigen 3 Short name=Ag3 Alternative name(s): Surface glycoprotein LFA-3 CD_antigen=CD58 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 250 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Ligand of the T-lymphocyte CD2 glycoprotein. This interaction is important in mediating thymocyte interactions with thymic epithelial cells, antigen-independent and -dependent interactions of T-lymphocytes with target cells and antigen-presenting cells and the T-lymphocyte rosetting with erythrocytes. In addition, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells. |
| Subcellular location | Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Cell membrane; Lipid-anchor › GPI-anchor. |
| Sequence similarities | Contains 1 Ig-like C2-type (immunoglobulin-like) domain. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing |
| Domain | Immunoglobulin domain Signal Transmembrane |
| PTM | GPI-anchor Glycoprotein Lipoprotein |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | cell-cell adhesion Non-traceable author statement. Source: UniProtKB |
| Cellular component | integral to plasma membrane Non-traceable author statement. Source: UniProtKB |
| Molecular function | protein binding Inferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | |||||
| Isoform 1 (identifier: P19256-1) Also known as: Long; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||
| Isoform 2 (identifier: P19256-2) Also known as: Short; The sequence of this isoform differs from the canonical sequence as follows: 236-237: GI → VL 238-250: Missing. | |||||
| Notes: GPI-anchored form. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | ||||||||||||||||||||||||||||||||||||||||
| Chain | 29 – 235 | 207 | Lymphocyte function-associated antigen 3 | |||||||||||||||||||||||||||||||||||||||
| Propeptide | 236 – 250 | 15 | Removed in mature form Probable | |||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 29 – 215 | 187 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||||
| Transmembrane | 216 – 238 | 23 | Potential | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 239 – 250 | 12 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||
| Domain | 135 – 194 | 60 | Ig-like C2-type | |||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||
| Lipidation | 235 | 1 | GPI-anchor amidated asparagine Probable | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 40 | 1 | N-linked (GlcNAc...) | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 94 | 1 | N-linked (GlcNAc...) | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 109 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 135 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 169 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 195 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 142 ↔ 187 | By similarity | ||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 236 – 237 | 2 | GI → VL in isoform 2. | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 238 – 250 | 13 | Missing in isoform 2. | |||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 30 – 36 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 41 – 43 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 54 – 58 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 61 – 67 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 70 – 73 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 75 – 77 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 80 – 83 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 85 – 87 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 90 – 92 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 97 – 99 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 101 – 106 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 114 – 121 | 8 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 128 – 132 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 133 – 136 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 137 – 141 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 149 – 154 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 157 – 170 | 14 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 178 – 184 | 7 | ||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein." Wallner B.P., Frey A.Z., Tizard R., Mattaliano R.J., Hession C., Sanders M.E., Dustin M.L., Springer T.A. J. Exp. Med. 166:923-932(1987) [PubMed: 3309127] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE. Tissue: Erythrocyte. |
| [2] | "An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2." Seed B. Nature 329:840-842(1987) [PubMed: 3313052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [3] | "Gene structure, promoter characterization, and basis for alternative mRNA splicing of the human CD58 gene." Wallich R., Brenner C., Brand Y., Roux M., Reister M., Meuer S. J. Immunol. 160:2862-2871(1998) [PubMed: 9510189] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2). |
| [4] | "An unappreciated role for RNA surveillance." Hillman R.T., Green R.E., Brenner S.E. Genome Biol. 5:RESEARCH008.1-RESEARCH008.16(2004) [PubMed: 14759258] [Abstract] Cited for: SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S). |
| [5] | "Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment." Elortza F., Mohammed S., Bunkenborg J., Foster L.J., Nuehse T.S., Brodbeck U., Peck S.C., Jensen O.N. J. Proteome Res. 5:935-943(2006) [PubMed: 16602701] [Abstract] Cited for: GPI-ANCHOR [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [6] | "Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution." Ikemizu S., Sparks L.M., van der Merwe P.A., Harlos K., Stuart D.I., Jones E.Y., Davis S.J. Proc. Natl. Acad. Sci. U.S.A. 96:4289-4294(1999) [PubMed: 10200255] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 29-122. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Y00636 mRNA. Translation: CAA68668.1. X06296 mRNA. Translation: CAA29622.1. Y14780 Y14784 Genomic DNA. Translation: CAA75083.1. Y14780 Y14785 Genomic DNA. Translation: CAA75084.1. | |||||||||||||||||||||||||
| PIR | A28564. | ||||||||||||||||||||||||
| RefSeq | NP_001770.1. | ||||||||||||||||||||||||
| UniGene | Hs.34341 | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSG00000116815. Homo sapiens. [Contig view] | ||||||||||||||||||||||||
| GeneID | 965. | ||||||||||||||||||||||||
| KEGG | hsa:965. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| H-InvDB | HIX0000929. | ||||||||||||||||||||||||
| HGNC | HGNC:1688. CD58. | ||||||||||||||||||||||||
| MIM | 153420. gene. | ||||||||||||||||||||||||
| PharmGKB | PA26227. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| HOGENOM | P19256. | ||||||||||||||||||||||||
| HOVERGEN | P19256. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P19256. | ||||||||||||||||||||||||
| CleanEx | HS_CD58. | ||||||||||||||||||||||||
| GermOnline | ENSG00000116815. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR007110. Ig-like. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR015714. Lymphocyte_antigen_3. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:2.60.40.10. Ig-like_fold. 1 hit. | ||||||||||||||||||||||||
| PANTHER | PTHR21063. lfa_3. 1 hit. | ||||||||||||||||||||||||
| SMART | SM00409. IG. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS50835. IG_LIKE. False negative. [Graphical view] | ||||||||||||||||||||||||
| ProDom | P19256. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||
| BLOCKS | Search... | ||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | LFA3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P19256 Secondary accession number(s): Q96KI9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| UniProtKB secondary accession numbers Index of UniProtKB secondary accession numbers |
| SIMILARITY comments Index of protein domains and families |

Clusters with


